Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08UML
|
|||
Former ID |
DNC013732
|
|||
Drug Name |
1-(Butan-2-ylidene)thiosemicarbazide
|
|||
Synonyms |
CHEMBL458405; 1752-40-5; AC1NSGXA; WLN: SUYZMNUY2& 2-butanone thiosemicarbazone; NSC709; NSC-709; [(Z)-butan-2-ylideneamino]thiourea; ZINC13115335; BDBM50268198
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C5H11N3S
|
|||
Canonical SMILES |
CCC(=NNC(=S)N)C
|
|||
InChI |
1S/C5H11N3S/c1-3-4(2)7-8-5(6)9/h3H2,1-2H3,(H3,6,8,9)/b7-4-
|
|||
InChIKey |
NCQXVINEPVAIDB-DAXSKMNVSA-N
|
|||
CAS Number |
CAS 1752-40-5
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tyrosinase (TYR) | Target Info | Inhibitor | [1] |
BioCyc | (S)-reticuline biosynthesis | |||
Eumelanin biosynthesis | ||||
L-dopachrome biosynthesis | ||||
KEGG Pathway | Tyrosine metabolism | |||
Riboflavin metabolism | ||||
Metabolic pathways | ||||
Melanogenesis | ||||
Pathwhiz Pathway | Riboflavin Metabolism | |||
Tyrosine Metabolism | ||||
WikiPathways | Dopamine metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds. Eur J Med Chem. 2009 Apr;44(4):1773-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.